J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M600167-JLR200 on November 8, 2006

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600167-JLR200v1
48/2/328    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berrougui, H.
Right arrow Articles by Khalil, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berrougui, H.
Right arrow Articles by Khalil, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 328-336, February 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

Age-related impairment of HDL-mediated cholesterol efflux

Hicham Berrougui*, Maxim Isabelle*, Martin Cloutier*, Guillaume Grenier*,{dagger} and Abdelouahed Khalil1,*,§

* Research Centre on Aging, Orthopaedic Service, University of Sherbrooke, Sherbrooke, Québec, Canada
{dagger} Department of Surgery, and Geriatric Service, University of Sherbrooke, Sherbrooke, Québec, Canada
§ Department of Medicine, University of Sherbrooke, Sherbrooke, Québec, Canada

Published, JLR Papers in Press, November 8, 2006.

1 To whom correspondence should be addressed. e-mail: abdelouahed.khalil{at}usherbrooke.ca


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Our aim in this study was to investigate the effect of aging on the capacity of HDLs to promote reverse cholesterol transport. HDLs were isolated from plasma of young (Y-HDL) and elderly (E-HDL) subjects. HDL-mediated cholesterol efflux was studied using THP-1 and J774 macrophages. Our results show that E-HDLs present a lower capacity to promote cholesterol efflux than Y-HDLs (41.7 ± 1.4% vs. 49.0 ± 2.2%, respectively; P = 0.013). Reduction in the HDL-mediated cholesterol efflux capacity with aging was more significant with HDL3 than HDL2 (Y-HDL3, 57.3 ± 1% vs. E-HDL3, 50.9 ± 2%; P = 0.012). Moreover, our results show that ABCA1-mediated cholesterol efflux is the more affected pathway in terms of cholesterol-removing capacity. Interestingly, the composition and structure of HDL revealed a reduction in the phosphatidylcholine-sphingomyelin ratio (E-HDL, 32.7 ± 2.7 vs. Y-HDL, 40.0 ± 1.9; P = 0.029) and in the phospholipidic layer membrane fluidity in E-HDL compared with Y-HDL as well as an alteration in the apolipoprotein A-I structure and charge. In conclusion, our results shown that E-HDLs present a reduced capacity to promote cholesterol efflux, principally through the ABCA1 pathway, and this may explain the increase of the incidence of cardiovascular diseases observed during aging.

Supplementary key words aging • reverse cholesterol transport • ATP binding cassette transporter A1 • apolipoprotein A-I • phospholipids • high density lipoproteins


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The inverse relationship between plasma levels of HDLs and cardiovascular disease has been demonstrated in several epidemiological and interventional studies (1, 2). The antiatherogenic properties of HDL have been ascribed to their abilities to inhibit LDL oxidation (3) and to prevent oxidized LDL-induced cytotoxicity and monocyte transmigration (4, 5). One of the long-standing mechanisms to explain the protective effect of HDLs against cardiovascular disease is their capacity to promote reverse cholesterol transport (RCT) (6).

The concept of RCT, as suggested by Glomset (7), consists of the movement of cholesterol from the peripheral tissues to the liver, which starts by the efflux of free cholesterol (FC) and phospholipids from cells of peripheral tissues to preß-migrating lipid-poor or lipid-free apolipoprotein A-I (apoA-I) and to HDL3 (7–9). The process of FC efflux occurs by three known pathways. 1) Aqueous diffusion. This process involves the desorption of FC molecules from the donor lipid-water interface and diffusion of these molecules through the intervening aqueous phase until they collide with and are absorbed by an acceptor. 2) Scavenger receptor class B type I (SR-BI)-mediated FC flux. The movement of FC via SR-BI is bidirectional, and like the aqueous diffusion mechanism, the net movement of FC via SR-BI depends on the direction of the cholesterol gradient (10). 3) ATP binding cassette-mediated cholesterol efflux. ABCA1 and ABCG1/4 are members of a large family of ATP-dependent transporters that share common structural motifs for the active transport of a variety of substrates (11). In contrast to aqueous diffusion and SR-BI-mediated FC flux, the movement of FC by ABCA1 and ABCG1/4 is unidirectional, and net efflux of cellular FCs would always occur via this mechanism (12). The preferred cholesterol acceptors for ABCA1 are lipid-poor apolipoproteins and all of the exchangeable apolipoproteins, such as apoA-I, apoA-II, apoA-IV, apoE, and apoC (13). ABCA1 has been shown to bind with apoA-I, indicating a very close association between the two proteins in mediating the cholesterol efflux process (14). Recently, it was shown that another transporter, ABCG1, promotes mass cholesterol efflux from cells to mature HDL particles (HDL2 and HDL3) but not to lipid-poor apoA-I (5,6). Both ABCA1 and ABCG1 are abundant in macrophages, especially after cholesterol loading, suggesting their importance for the cholesterol efflux process.

Cholesterol efflux was also correlated to HDL lipid composition and structure (12). As an example, phosphatidylcholine (PC)-enriched HDL increases cholesterol efflux, whereas sphingomyelin (SPM)-enriched HDL decreases cholesterol influx to macrophages (12). Moreover, several lipids that are common constituents of HDL are known to significantly affect the fluidity of lipid surfaces (e.g., PC and SPM) (15). Indeed, the phospholipid fatty acyl composition of lipoproteins is known to have subtle but measurable effects on the fluidity of the lipoprotein phospholipidic layer (15, 16). These changes may affect the ability of HDL particles to accommodate FC molecules that have desorbed from peripheral cells. Additionally, oxidative modifications of HDL affect its capacity to promote cholesterol efflux (17). Indeed, the formation of peroxidation-derived lipid products is associated with changes of the physicochemical properties of HDL and especially a decrease in the fluidity of the HDL phospholipid layer (17).

In previous studies, we have demonstrated that HDLs from elderly subjects are more prone to lipid peroxidation (18) and present a significant reduction of their antioxidant property, along with a decrease in paraoxonase 1 activity (19). In this study, we investigated the capacity of HDL to promote cholesterol efflux during aging with the aim of elucidating the biophysical and biochemical changes that influence this process. Hence, our results will contribute to a better understanding of the age-related increase in the incidence of cardiovascular disease.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals
Acetic acid, sulfuric acid, sodium phosphate, thiobarbituric acid, n-butanol, methanol, ethanol, n-isopropanol, hexane, ammonium hydroxide, chloroform, and methanol were purchased from Fisher (Montréal, Québec, Canada). 1,1,3,3,-Tetraethoxypropane, D-{alpha}-tocopherol, {gamma}-tocopherol, butylated hydroxytoluene, CuSO4, EDTA, lithium perchlorate, 1,6-diphenyl-1,3,5-hexatriene, PC, SPM, 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate (cAMP), and [3H]cholesterol were obtained from Sigma (St. Louis, MO). THP-1 and J774 cells were purchased from the American Type Culture Collection (Manassas, VA).

Subjects
Plasma was obtained from healthy volunteers (eight young, aged 20–30 years, and nine elderly, aged 65–70 years). Their demographic data are shown in Table 1 . All subjects were considered healthy because they were normolipidemic and had normal blood pressure. No subjects showed clinical signs of inflammation or diabetes. They were free of any medication, including lipid-lowering medications, and no oral antioxidant supplementation was used. They were all nonsmokers, and none of the women was currently taking estrogen replacement therapy for menopause. The elderly subjects were living at home, functionally independent, and cognitively intact (Mini Mental State Examination > 28). The Ethics Committee of the Sherbrooke Geriatric University Institute approved the study, and all subjects gave written informed consent.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Demographic and biochemical parameters of the study subjects

 
Lipoprotein isolation
Human plasma was collected in citrate tubes, and HDL isolations were performed immediately according to the method of Sattler, Mohr, and Stocker (20). Isolated lipoproteins were dialyzed overnight at 4°C in 10–2 M sodium phosphate buffer (pH 7.0), and then the protein concentrations were measured by commercial assay (Bio-Rad, Mississauga, Ontario, Canada).

ApoA-I purification
ApoA-I was purified from HDLs obtained from young and elderly subjects according to the method of Haidar et al. (21). Briefly, HDLs were delipidated in acetone-ethanol solution, and the protein fractions were subjected to chromatographic separation using two Sephacryl S-200 columns (Amersham Biosciences AB, Uppsala, Sweden). ApoA-I pure fractions were pooled and dialyzed in 100 mM NH4HCO3, then lyophilized and resuspended in phosphate buffer solution.

Cell culture
Human THP-1 monocytes and J774 macrophages were grown in RPMI 1640 and DMEM medium, respectively. The media were supplemented with 10% heat-inactivated FBS, 2-ß-mercaptoethanol (only for THP-1; 50 µM), L-glutamine (2 mM), glucose (1.5 mg/ml), and antibiotic (penicillin; 100 U/ml).

Differentiation of THP-1 monocytes into macrophages was induced by plating the cells at a density of 1.0 x 105 cells/cm2 in the presence of 100 nM phorbol myristate acetate for 96 h.

Cholesterol efflux measurement
THP-1 and J774 macrophages were incubated in fresh growth medium containing [3H]cholesterol (0.2 µCi/ml) for 48 h. Labeled cells were washed and then incubated in serum-free medium containing 1% BSA for 24 h of equilibration. The cells were then washed and subjected to different treatments: 1) fresh medium without HDL (control); 2) fresh medium containing 50 µg/ml HDL; and 3) fresh medium containing 50 µg/ml HDL3 or HDL2, obtained from young and elderly subjects.

In another series of experiments, J774 macrophages were labeled with [3H]cholesterol (2 µCi/ml) for 24 h. The cells were then washed and incubated with 0.2% BSA in DMEM alone or with 0.3 mM cAMP for 12 h to yield ABCA1-enriched cells (22). Then, the cells were washed and further incubated for 4 h at 37°C in the presence of whole HDL, HDL subfractions (HDL3 and HDL2), or apoA-I obtained from young and elderly subjects.

Cholesterol efflux was determined by liquid scintillation counting, and the percentage of radiolabeled cholesterol released (percent cholesterol efflux) was calculated as (cpm in medium/[cpm in the cell + medium]) x 100.

Net cholesterol efflux was also assayed by measuring cell cholesterol mass content. Briefly, cellular lipids were extracted from 2 x 106 J774 cells with hexane-isopropanol (3:2, v/v), and the hexane phase was dried under nitrogen. Total cholesterol concentrations in cells as well as in culture medium were measured by HPLC according the method of Katsanidis and Addis (23).

Western blotting and PCR analysis
Twenty five micrograms of cell lysate proteins was loaded per line and separated by 7.5% SDS-PAGE. After transfer, membranes were incubated with specific antibodies against ABCA1 (Santa Cruz Biotechnology, Santa Cruz, CA). Anti-goat IgG-HRP antibody (Santa Cruz Biotechnology) was directed against the primary antibody, and protein was detected using a chemiluminescent reagent (ECL).

RNA was extracted from J774 cells using the RNeasy mini kit (Qiagen) and reverse transcribed using the GeneAmp kit (Applied Biosystems). Reverse-transcribed RNA was used for PCR analysis with the following primer sequences (F, forward; R, reverse): ß-actin (F, 5'-CACCCTGTGCTGCTCACCGAGGCC-3'; R, 5'-ACCGCTCGTTGCCAATAGTGATGA-3'); ABCA1 (F, 5'-GCCCTACTGTCGGTTGAC-3'; R, 5'-TGGGCAACACTGAACAAGAG-3'); and ABCG1 (F, 5'-TCAACAGTGGAGAGCTGGTG-3'; R, 5'-CTGCCTTCATCCTTCTC-3'). All reactions were run at least in triplicate.

Copper-mediated HDL oxidation
Lipoprotein peroxidation was carried out as described previously using copper ions as an oxidizing agent (24).

Conjugated diene and thiobarbituric acid-reactive substance evaluation
HDL peroxidation was monitored continuously at 234 nm to detect the formation of conjugated diene, as described previously (17). Thiobarbituric acid-reactive substances, mainly malondialdehyde, were assayed by HPLC coupled to fluorescence detection (25).

ApoA-I modification
ApoA-I was analyzed as described by Laemmli (26) on 12.5% SDS-PAGE gels (Mini Gel II; Bio-Rad, Hercules, CA). Each lane was loaded with 8 µg of protein of native or oxidized HDL (for 0, 1, 4, and 8 h). Gels were stained with Coomassie Brilliant Blue.

ApoA-I modifications were also evaluated by measuring the HDL surface charge and for the presence of apoA-I carbonyl groups. Oxidative modification of HDL (apoA-I) results in an increase in net negative charge, which can be detected using agarose electrophoresis (Titan gel lipoprotein electrophoretic system). Relative electrophoretic mobility was calculated as the ratio of the electrophoretic mobility of the samples to that of native HDL of young subjects (Y-HDL). Ratio values of >1 indicate an increase of the negative charge compared with native Y-HDL. HDL electrophoresis was carried out in barbital buffer at pH 8.6 on 0.6% agarose gels (Helena Laboratories, Montreal, Québec, Canada). The gels were stained with 0.1% (w/v) Fat Red 7B in 95% methanol.

ApoA-I-bound carbonyl content was assayed as described by Levine et al. (27). Briefly, apoA-I was purified from HDL as described previously (27). The carbonyl content were determined by dinitrophenylhydrazine derivatization. ApoA-I-bound carbonyls were detected in TCA-precipitable materials by absorbance at 370 nm ({epsilon} = 22,000 M–1 cm–1).

HDL fluidity
Lipoprotein fluidity was determined by steady-state anisotropy of 1,6-diphenyl-1,3,5-hexatriene as described previously (28). Fluidity represents the inverse values of anisotropy and is expressed as 1/r (for steady-state fluorescence anisotropy). r was calculated as [(Iv – GIp)/(Iv – 2GIp)], where Iv and Ip are the parallel and perpendicular polarized fluorescence intensities and G is the monochromator grating correction factor.

HDL phospholipid analysis
Total lipids were extracted using a modified method of Folch, Lees, and Sloane-Stanley (29). One hundred microliters of lipid extract was then injected into an HPLC system coupled to an evaporative light-scattering detector according to the method of Becart, Chevalier, and Biesse (30). Solvent eluents were prepared according to a binary gradient (A, chloroform-methanol-ammonium hydroxide at 30%: 80/19.5/0.5; B, chloroform-methanol-water-ammonium hydroxide at 30%: 60/34/5.5/0.5).

Statistical analysis
Values are expressed as means ± SEM. One-way ANOVA was used for multiple comparisons. Linear regression analysis was used to assess the association between two continuous variables, and the t-test was used to assess the comparison between two groups. Statistical analyses were performed using Prism version 4.0.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Effect of aging on HDL-mediated cholesterol efflux
The biochemical characteristics of participating subjects are reported in Table 1. The two age groups had no significant differences in their body mass index, total cholesterol, or LDL and HDL cholesterol. ApoA-I concentrations were in the same range for young and elderly subjects, and the acute inflammation phase protein C-reactive protein was below detection levels for both age groups (<3 mg/l).

To examine the effect of aging on the antiatherogenic activities of HDL and particularly their ability to promote RCT, we assessed the capacity of HDL obtained from young (Y-HDL) and elderly (E-HDL) healthy subjects to enable cholesterol efflux. A time course (0–48 h) on cholesterol efflux revealed differences between Y-HDL and E-HDL that were manifested with 50 µg/ml HDL after 24 h of incubation (Fig. 1 ). In fact, when Y-HDL and E-HDL were incubated for 24 h with THP-1 macrophages preloaded with radiolabled [3H]cholesterol, cholesterol efflux promoted by Y-HDL was significantly higher by 14.9% (P < 0.05) than that promoted by E-HDL. The amounts of cholesterol efflux promoted by Y-HDL and E-HDL were dependent on the incubation time with macrophages and reached a maximum after 24 h of incubation, this is in agreement with previous results published by Nagano, Arai, and Kita (31). The measure of cholesterol mass in the media and in cells also demonstrated a higher significant capacity of Y-HDL to mediate net cholesterol efflux than E-HDL (P = 0.023).


Figure 1
View larger version (15K):
[in this window]
[in a new window]

  		Fig. 1. Effects of aging on HDL-mediated cholesterol efflux. Whole HDL, HDL2, and HDL3 (50 µg/ml) were isolated from young (Y-HDL) and elderly (E-HDL) subjects and incubated with [3H]cholesterol-loaded THP-1 macrophages for 24 h. Cholesterol efflux was determined by measuring [3H]cholesterol recuperated by HDL. Results are expressed as means ± SEM (n > 4). * P < 0.05.

 
To gain more insight into the effect of aging on HDL-mediated cholesterol efflux, we assessed the capacity of different HDL subfractions to promote cholesterol efflux, in particular HDL2 and HDL3. Under our conditions, HDL2 and HDL3 were isolated by ultracentrifugation, which excluded the presence of preß1-HDL in our preparations, thus eliminating its possible role in the difference of the RCT capacity between young and elderly (32, 33).

We subsequently sought to determine, first, which HDL subfraction (HDL2 or HDL3) was more implicated in the HDL-mediated cholesterol efflux from macrophages, and second, the effect of aging in this process. Whole HDL, HDL2, and HDL3 isolated from both young and elderly subjects were incubated separately for 24 h with [3H]cholesterol-loaded THP-1 macrophages. Y-HDL3 induced significantly a higher [3H]FC efflux (9.7% higher; P < 0.05) than that induced by Y-HDL2, whereas no differences were apparent between E-HDL3 and E-HDL2 (Fig. 1). When regarded as a function of aging, Y-HDL3 showed a higher capacity to promote cholesterol efflux than E-HDL3 (11.1% higher; P < 0.05), with no observed variations between Y-HDL2 and E-HDL2.

Effect of aging on the ABCA1-mediated cholesterol efflux pathway
To clarify which of the cholesterol efflux pathways was more affected by aging, we investigated the mechanism based on the ABCA1 protein using a second macrophage cell line, J774. J774 cells express less ABCA1 compared with THP-1 macrophages (9), as confirmed by our results (Fig. 2A ).


Figure 2
View larger version (14K):
[in this window]
[in a new window]

  		Fig. 2. A: ABCA1 protein expression level in THP-1 and J774 macrophages. Protein lysates (20 µg) of each lysed cell line were loaded onto SDS-PAGE gels (7.5%) in reduced conditions and immunoblotted with ABCA1-specific antibodies. Quantitative analysis was determined using densitometry from three independent experiments. Results are expressed as means ± SEM. ** P < 0.01. B: Comparison of HDL-mediated cholesterol efflux from THP-1 and J774 macrophages. THP-1 and J774 macrophages loaded with [3H]cholesterol were incubated for 24 h with Y-HDL and E-HDL (50 µg/ml). Results are expressed as means ± SEM of triplicate determinations (n = 4). *** P < 0.001, Y-HDL in THP-1 cells versus Y-HDL in J774 cells. ### P < 0.001, E-HDL in THP-1 cells versus E-HDL in J774 cells.

 
Interestingly, when Y-HDL and E-HDL (50 µg/ml) were incubated separately with [3H]cholesterol-loaded J774 cells during 24 h, there was no effect of aging on the capacity of either HDL to promote cholesterol efflux compared with the THP-1 cells (Fig. 2B). Furthermore, we chemically induced overexpression of ABCA1 by J774 to analyze the effect of aging on the ABCA1 cholesterol efflux-related pathway. Our results indicate that J774 cells stimulated with cAMP have a robust expression of ABCA1 (>9-fold) compared with nonstimulated cells (Fig. 3A ). Interestingly, the modulation of expression of ABCG1 by cAMP was <1.8-fold.


Figure 3
View larger version (30K):
[in this window]
[in a new window]

  		Fig. 3. Involvement of the ABCA1 receptor in HDL-mediated cholesterol efflux in J774 cells. J774 macrophages were incubated for 12 h at 37°C without (control cells) or with 0.3 mM 8-Br-cAMP. A: 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (cAMP) regulates mRNA expression of ABCA1 and ABCG1 in J774 cells. One representative PCR analysis is shown for ABCA1, ABCG1, and ß-actin. The graph at right represents the transcriptional expression of ABCA1 and ABCG1. ß-Actin was used as an internal control. Expression of ABCG1 is slightly regulated after cAMP stimulation (<2-fold) compared with ABCA1, which is highly regulated (>9-fold), compared with control cells (nonstimulated). Asterisks denote significance for ABCA1 (* P = 0.034) and ABCG1 (** P = 0.0009). B: Stimulated or nonstimulated J774 cells were incubated during 24 h with HDL or HDL3 isolated from young (Y-HDL) or elderly (E-HDL) subjects (50 µg/ml). C: Apolipoprotein A-I (apoA-I)-mediated cholesterol efflux between ABCA1-enriched and control cells. Cells were treated with apoA-I (50 µg/ml) purified from young (Y-apoA-I) and elderly (E-apoA-I) subjects. Results represent means ± SEM of more than three different experiments.

 
The chemically induced expression of ABCA1 in J774 cells by cAMP (21, 34, 35) significantly increased whole HDL- and HDL3-mediated cholesterol efflux in both young and elderly subjects (Fig. 3B), whereas no differences were observed in HDL2-related cholesterol efflux as a function of aging (results not shown). Moreover, in ABCA1-enriched J774 cells, Y-HDL increased cholesterol efflux by 21.7% (P < 0.05) compared with E-HDL, whereas Y-HDL3 enhanced cholesterol efflux by 26.1% (P < 0.001) compared with E-HDL3 (Fig. 3B).

ApoA-I purified from young subjects (Y-apoA-I) and elderly subjects (E-apoA-I) was also evaluated for its capacity to promote cholesterol efflux (Fig. 3C). Our results do not shown an effect of aging on the apoA-I-dependent cholesterol efflux from control J774 cells. However, in ABCA1-enriched J774 cells, E-apoA-I was significantly less efficient at mediating cholesterol efflux than Y-apoA-I (P = 0.0048) (Fig. 3C).

ApoA-I structure and HDL cholesterol efflux capacity
The ABCA1-mediated cholesterol efflux pathway is dependent on the interaction of apoA-I with the ABCA1 receptor. Thus, alteration or modification of apoA-I protein could modulate the HDL cholesterol efflux capacity. For this purpose, we used SDS-PAGE to compare the apoA-I modification level as a function of aging. Interestingly, for the same HDL concentration expressed in terms of total protein content, Y-HDL demonstrated a higher apoA-I band intensity than E-HDL (Fig. 4A ).


Figure 4
View larger version (10K):
[in this window]
[in a new window]

  		Fig. 4. A: SDS-PAGE profiles of apoA-I in basal conditions and during HDL oxidation. Y-HDL and E-HDL (200 µg/ml) were incubated with 10 µM CuSO4 for 0, 1, 4, and 8 h. Experiments were performed in triplicate, and the gel shown is typical of the results obtained. Results were also analyzed by densitometry and represented as means ± SEM of three-separate experiments (densitometric data of young and elderly for the same time of oxidation were compared). ** P < 0.01, *** P < 0.001. B: Relative electrophoretic mobility analysis of HDL. Y-HDL and E-HDL (200 µg/ml) were incubated with 10 µM CuSO4 for 0, 1, and 4 h. HDL electrophoresis was carried out in barbital buffer at pH 8.6 on 0.6% agarose gels. The gels were stained with 0.1% Fat Red 7B in 95% methanol. C: Involvement of apoA-I protein in HDL-mediated CE. [3H]cholesterol-loaded THP-1 macrophages were incubated for 24 h with 50 µg of native or oxidized Y-HDL or E-HDL. Cholesterol efflux was determined as mentioned above. Results are expressed as means ± SEM of triplicate determinations. * P < 0.05.

 
Submission of Y-HDL and E-HDL to oxidative stress induced by copper ions and followed by the measurement of apoA-I by electrophoresis resulted in a reduction in the apoA-I band intensity, as shown in Fig. 4A. At higher oxidative stress (4 and 8 h), the apoA-I band was reduced dramatically as consequence of the oxidative modifications. The relative electrophoretic mobility (Fig. 4B, Table 2 ) also demonstrated an alteration of the apoA-I charge as a function of aging and HDL oxidation intensity. In addition, our results show that protein carbonyl content was 38% greater in E-apoA-I than in Y-apoA-I (1.1 ± 0.1 vs. 1.7 ± 0.1 µM; P = 0.04) (see supplementary data).


View this table:
[in this window]
[in a new window]

  		TABLE 2. HDL relative electrophoretic mobility as a function of aging (Y-HDL vs. E-HDL) and HDL oxidation intensity (0, 1, 2, and 4 h)

 
Oxidative modification of Y-HDL and E-HDL induces a significant reduction of HDL capacity to promote cholesterol efflux (Fig. 4C). It is noteworthy that for the same level of oxidation (incubation times of 0 and 1 h), Y-HDLs show a higher capacity to promote cholesterol efflux than E-HDLs (P < 0.05) (Fig. 4C).

Interestingly, comparison of HDL oxidation kinetics as a function of the age of donors shows an increased susceptibility of HDL to lipid peroxidation with aging, as measured by the lag phase for conjugated diene and malondialdehyde formation (Table 3 ).


View this table:
[in this window]
[in a new window]

  		TABLE 3. Effect of aging on the susceptibility of HDL to lipid peroxidation

 
Effect of aging on the ABCA1/apoA-I-independent pathway for cholesterol efflux
To investigate the influence of other HDL components on cholesterol efflux capacity as a function of aging, we evaluated the HDL phospholipid contents and performed fluorescence anisotropy assays as an indirect measurement for HDL phospholipid bilayer fluidity.

For the phospholipid contents, we focused on the measurement of the HDL PC/SPM ratio. This parameter was shown previously to significantly influence HDL-mediated cholesterol efflux capacity (12, 36) as an ABCA1/apoA-I-independent pathway. Figure 5A demonstrates a significant decrease in the PC/SPM ratio in whole HDLs obtained from elderly subjects compared with those obtained from young subjects (P = 0.029). Similar results were obtained for E-HDL3 compared with Y-HDL3 (P = 0.0027) (Fig. 5A).


Figure 5
View larger version (19K):
[in this window]
[in a new window]

  		Fig. 5. A: Effects of aging on the phospholipid composition of whole HDL and HDL subfractions (HDL2 and HDL3) isolated from young and elderly patients. Results are given as phosphatidylcholine (PC) and sphingomyelin (SPM) ratio (PC/SPM). B: Effect of aging on the fluidity of the phospholipidic bilayer of whole HDL, HDL3, and HDL2, isolated from young and elderly subjects. Results are expressed as means ± SEM (n = 4–7). * P < 0.05, *** P < 0.001.

 
With fluorescence anisotropy, Y-HDL was found to have higher and significant phospholipidic layer fluidity than E-HDL (P < 0.001). The same results were obtained for Y-HDL2 (P = 0.035) and Y-HDL3 (P = 0.023) compared with the same HDL subfractions from elderly subjects (Fig. 5B).


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The severity of atherosclerosis and the incidence of its clinical manifestations increase dramatically with aging and are responsible for the majority of cardiovascular morbidity and mortality in the elderly. High plasma levels of HDLs are associated with a decreased risk of developing atherosclerosis, an effect commonly attributed to their central role in RCT. Indeed, efflux of FC from cell membranes to extracellular acceptors is considered to represent one of the first steps in the process of RCT.

Aging is characterized by the occurrence of several physical and biochemical modifications that affect HDL structure and functions (18, 37, 38). Previous studies from our laboratory have shown an increase of HDL susceptibility to lipid peroxidation and a decrease of HDL antioxidant activity with aging (18, 19). We investigated the effects of aging on the RCT process by studying the antiatherogenic properties of HDL. Our results showed a significant reduction of the whole HDL capacity to promote cholesterol efflux from macrophages. To determine which HDL subfraction was more affected, HDL2 and HDL3 were isolated and evaluated for their capacity to mediate cholesterol efflux. Interestingly, the reduction in the cholesterol efflux with aging was significant only for HDL3. Moreover, in the young subject group, a difference in the capacity of HDL subfractions (Y-HDL2 and Y-HDL3) to promote cholesterol efflux was demonstrated (Y-HDL3; P = 0.019). However, no significant difference was observed between E-HDL2 and E-HDL3. The ability of HDL3 to increase cellular cholesterol efflux has been attributed to the increased presence of LCAT (39), greater phospholipidic bilayer fluidity, higher cholesteryl ester content, increased linoleic-to-linolenic acid ratio in phospholipids, and smaller size (40). Moreover, ABCA1 transporters, by binding to and cross-linking with lipid-poor apoA-I, represent another parameter that might explain the difference between the Y-HDL and E-HDL cholesterol-promoting efficiencies. The purpose of carrying out our experiments in more than one cell type was to confirm the notion of the ABCA1 receptor's role in the dissimilarity between Y-HDL and E-HDL, and especially between E-apoA-I and Y-apoA-I, to promote cholesterol efflux as a function of aging. Indeed, when J774 control cells were used, no difference was observed between Y-HDL and E-HDL or between E-apoA-I and Y-apoA-I in RCT activity, which is not the case with THP-1 macrophages. This could be attributable to the differences in the expression of ABCA1 receptors between the two cell lines or to differences in the release of lipid-free apoA-I from the two HDL samples. Moreover, evidence indicates that ABCA1 forms a high-affinity complex with apoA-I by binding amphipathic helices within the apolipoprotein (14, 41). Oxidative modifications of apoA-I that might occur with aging may affect the ABCA1-apoA-I interaction, leading to the reduction of cholesterol efflux.

ApoA-I availability, which can be affected by a reduction in its concentration as well as by a structural alteration, may affect cholesterol efflux capacity. SDS-PAGE analysis showed a reduction in the apoA-I band intensity in E-HDL compared with Y-HDL, which suggests a reduction in apoA-I concentration in the elderly, as was demonstrated recently (37). However, for the electrophoresis experiments, Y-HDL as well as E-HDL were used at the same protein concentration (50 µg/ml), which excludes attributing the reduction in apoA-I band intensity to a reduction of its concentration. Indeed, no significant change in apoA-I concentration was noted between young and elderly subjects (Table 1). Interestingly, HDL incubation with copper ions induced a significant reduction of apoA-I band intensity (Fig. 4A) and an increase in the apoA-I negative charge. For the same incubation time, apoA-I oxidative modifications with copper ions were more pronounced for E-HDL than for Y-HDL. Together, these results suggest that the basal alteration of apoA-I structure, as reflected by the decreased band intensity and charge as well as by the increase in bound carbonyls, might be reflective of age-related oxidative stress conditions. Moreover, they might explain, at least in part, the difference as a function of aging in the ABCA1-mediated cholesterol efflux capacity of HDL.

Furthermore, our results show that in both young and elderly subjects, the capacity of HDL to remove FC excess from macrophages decreases significantly with higher levels of HDL oxidation. Interestingly, for the same level of HDL peroxidation, cholesterol efflux capacity was higher for Y-HDL than for E-HDL. Moreover, HDL oxidation induces an apoA-I alteration and decreases HDL phospholipidic layer fluidity.

Besides the expression levels of ABCA1, cholesterol efflux from macrophages is also dependent on the biophysical and biochemical structures of HDL subfractions. Contrary to the ABCA1-mediated cholesterol efflux, the other implicated mechanisms, ABCG1 and ABCG4, the spontaneous transfer, and the SR-BI pathways, all involve cholesterol transfer to phospholipid-containing species, principally HDL2 (42). Thus, one might expect that alteration or change in the HDL phospholipid composition or structure would affect RCT (42–44). Analysis of the HDL, HDL2, and HDL3 phospholipid composition as a function of donor age showed a significant decrease in the PC/SPM ratio in the elderly. The increase of PC was demonstrated to positively modulate the RCT (45). These results, corroborated by the measure of reduced HDL fluidity, might be attributed in part to the oxidative modifications that occur with aging, as shown previously for apoA-I.

HDL-mediated cholesterol efflux capacity has been demonstrated to be reduced in diabetes (46), in subjects with familial HDL deficiency (47), and in Tangier disease (48) and has been associated with an alteration in HDL concentration, distribution, or composition and structure. In vitro studies have shown that HDL-mediated cholesterol efflux is impaired by whole cigarette smoke extracts through lipid peroxidation (49). Furthermore, cholesterol efflux could be affected by the inactivation of enzymes contained within HDL, particularly paraoxonase 1 and LCAT. Rosenblat, Karry, and Aviram (34) demonstrated a function of paraoxonase 1 in reverse cholesterol efflux from macrophages. Interestingly, a study from our laboratory has shown a significant reduction of paraoxonase 1 activity in the elderly (19).

Moreover, unlike ABCA1, ABCG1 and ABCG4 stimulate cholesterol efflux, especially to HDL2 and HDL3 but not to lipid-poor apoA-I (50). In this case, the HDL physicochemical changes that occur during aging may directly affect the interaction between HDL subfractions and ABCG1/4, leading to an attenuation of cholesterol efflux. The possible relationship between ABCG1/4 and cholesterol efflux during aging warrants further investigation. In addition to these ATP-dependent transporters, Ji et al. (51) have showed that SR-BI promotes a bidirectional flux between cells and HDL and also facilitates net cholesterol efflux to phospholipid-rich and cholesterol-poor HDL but not to lipid-poor apoA-I. However, Zhang et al. (52) demonstrated that SR-BI knockout macrophages display no difference in cholesterol efflux to HDL compared with wild-type macrophages, suggesting that SR-BI does not have a major role in cholesterol efflux to HDL.

In summary, our results have shown an impairment of HDL-mediated RCT capacity with aging that has been attributed to a reduction in the ABCA1 pathway. Based on these data, we postulate that the ABCA1/apoA-I-dependent cholesterol efflux is the more affected pathway with aging and is attributable principally to the oxidative modifications of apoA-I that might occur during aging. However, HDL biophysical and biochemical changes are also contributing factors in the reduction of its capacity to mediate cholesterol efflux in the elderly. Although the results obtained did not allow us to determine the proportion of cholesterol efflux that could be attributed to ABCG1/4 or SR-BI, we hypothesize that HDL structure and composition alterations could also affect these pathways of cholesterol efflux. In conclusion, the reduced capacity of E-HDL to promote cholesterol efflux may explain the increase in the incidence of cardiovascular diseases observed during aging.


   ACKNOWLEDGMENTS
 
This work was supported by a grant from the Canadian Institute of Health Research (IAO-63150). H.B. is the recipient of a studentship from the Québec-based Strategic Training Program in Aging (FORMSAV). A.K. is a Junior 2 Fellow of the Fonds de Recherche en Santé du Québec. The authors thank Dr. Anthony Scimè for critical reading of the manuscript.

Manuscript received April 11, 2006 and in revised form October 30, 2006.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Wilson, P. W., R. D. Abbott, and W. P. Castelli. 1988. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis. 8: 737–741.[Abstract/Free Full Text]

  2. Thom, T., N. Haase, W. Rosamond, V. J. Howard, and the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2006. Heart disease and stroke statistics—2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 113: 85–151.[CrossRef]

  3. Parthasarathy, S., J. Barnett, and L. G. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044: 275–283.[Medline]

  4. Suc, I., I. Escargueil-Blanc, M. Troly, R. Salvayre, and A. Nègre-Salvayre. 1997. HDL and apoA-I prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 17: 2158–2166.[Abstract/Free Full Text]

  5. Wang, N., D. Lan, W. Chen, F. Mastuura, and A. R. Tall. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA. 101: 9774–9779.[Abstract/Free Full Text]

  6. Kennedy, M. A., G. C. Barrera, K. Nakamura, A. Baldan, P. Tarr, M. C. Fishbein, J. Frank, O. L. Francone, and P. A. Edwards. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2: 121–131.

  7. Glomset, J. A. 1968. The plasma lecithins cholesterol acyltransferase reaction. J. Lipid Res. 9: 155–167.[Abstract]

  8. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25–29.[CrossRef][Medline]

  9. Bortnick, A. E., G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone. 2000. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634–28640.[Abstract/Free Full Text]

  10. de la Llera-Moya, M., M. A. Connelly, D. Drazul, S. M. Klein, E. Favari, P. G. Yancey, D. L. Williams, and G. H. Rothblat. 2001. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J. Lipid Res. 42: 1969–1978.[Abstract/Free Full Text]

  11. Dean, M., Y. Hamon, and G. Chimini. 2001. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42: 1007–1017.[Abstract/Free Full Text]

  12. Yancey, P. G., M. de la Llera-Moya, S. Swarnakar, P. Monzo, M. S. Klein, A. Connelly, W. J. Johnson, D. L. Williams, and G. H. Rothblat. 2000. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275: 36596–36604.[Abstract/Free Full Text]

  13. Remaley, A. T., J. A. Stonik, S. J. Demosky, E. B. Neufeld, A. V. Bocharov, T. G. Vishnyakova, T. L. Eggerman, A. P. Patterson, N. J. Duverger, S. Santamarina-Fojo, et al. 2001. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280: 818–823.[CrossRef][Medline]

  14. Oram, J. F., R. M. Lawn, M. R. Garvin, and D. P. Wade. 2000. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275: 34508–34511.[Abstract/Free Full Text]

  15. Johnson, W. J., F. H. Mahlberg, G. H. Rothblat, and M. C. Phillips. 1991. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta. 1085: 273–298.[Medline]

  16. Sola, R., M. F. Baudete, C. Motta, M. Maille, C. Boisnier, and B. Jacotot. 1990. Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim. Biophys. Acta. 1043: 43–51.[Medline]

  17. Bennefont-Rousselot, D., C. Motta, A. Khalil, R. Sola, A. K. La Ville, J. Delattre, and M. Gardés-Albert. 1995. Physiochemical changes in human high density lipoproteins (HDL) oxidized by gamma-radiolysis generated oxyradicals. Biochim. Biophys. Acta. 1255: 23–30.[Medline]

  18. Khalil, A., J. P. Jay-Gerin, and T. Fülöp, Jr. 1998. Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by gamma-radiolysis of water. FEBS Lett. 435: 153–158.[CrossRef][Medline]

  19. Jaouad, L., C. de Guise, H. Berrougui, M. Cloutier, M. Isabelle, T. Fulop, H. Payette, and A. Khalil. 2006. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydyl groups. Atherosclerosis. 185: 191–200.[CrossRef][Medline]

  20. Sattler, W., D. Mohr, and R. Stocker. 1994. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol. 233: 469–489.[Medline]

  21. Haidar, B., M. Denis, L. Krimbou, M. Marcil, and J. Genest. 2002. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res. 43: 2087–2094.[Abstract/Free Full Text]

  22. Hajj Hassan, H., S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest. 2005. Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release. J. Lipid Res. 46: 1457–1465.[Abstract/Free Full Text]

  23. Katsanidis, E., and P. B. Addis. 1999. Novel HPLC analysis of tocopherols, tocotrienols, and cholesterol in tissue. Free Radic. Biol. Med. 27: 1137–1140.[CrossRef][Medline]

  24. Khalil, A., J. P. Fortin, J. G. LeHoux, and T. Fülöp. 2000. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation. J. Lipid Res. 41: 1552–1561.[Abstract/Free Full Text]

  25. Agarwal, R., and S. D. Chase. 2002. Rapid, fluorometric-liquid chromatographic determination of malondialdehyde in biological samples. J. Chromatogr. B. 775: 121–126.

  26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680–685.[CrossRef][Medline]

  27. Levine, R. L., D. Garland, C. N. Oliver, A. Amici, I. Climent, A. G. Lenz, B. W. Ahn, S. Shaltiel, and E. R. Stadtman. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186: 464–478.[Medline]

  28. Beck, R., S. Bertolino, S. E. Abott, P. I. Aaronson, and S. V. Smimou. 1998. Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth and endothelial cells. Circ. Res. 83: 923–931.[Abstract/Free Full Text]

  29. Folch, J., M. Lees, and A. Sloane-Stanley. 1957. Simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 22: 6497–6509.

  30. Becart, J., C. Chevalier, and J. P. Biesse. 1999. Quantitative analysis of phospholipids by HPLC with a light scattering evaporating detector—application to raw materials for cosmetic use. J. High Res. Chromatogr. 13: 126–129.

  31. Nagano, Y., H. Arai, and T. Kita. 1991. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. USA. 88: 6457–6461.[Abstract/Free Full Text]

  32. Chétiveaux, M., H. Nazih, V. Ferchaud-Roucher, G. Lambert, Y. Zaïr, M. Masson, K. Ouguerram, D. Bouhours, and M. Krempf. 2002. The differential apoA-I enrichment of preß1 and HDL is detectable by gel filtration separation. J. Lipid Res. 43: 1986–1993.[Abstract/Free Full Text]

  33. Sviridov, D., O. Miyazaki, K. Theodore, A. Hoang, I. Fukamachi, and P. Nestel. 2002. Delineation of the role of pre-ß1-HDL in cholesterol efflux using isolated pre-ß1 HDL. Arterioscler. Thromb. Vasc. Biol. 22: 1482–1488.[Abstract/Free Full Text]

  34. Rosenblat, M., R. Karry, and M. Aviram. 2006. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Atherosclerosis. 187: 74–81.[CrossRef][Medline]

  35. Yancey, P. G., A. E. Bortnick, G. Kellner-Weibel, M. de la Llera-Moya, M. C. Phillips, and G. H. Rothblat. 2003. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23: 712–719.[Abstract/Free Full Text]

  36. Jiang, X. C. 2002. The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis. Front. Biosci. 7: 1634–1641.

  37. Seres, I., G. Paragh, E. Deschene, T. Fulop, Jr., and A. Khalil. 2004. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp. Gerontol. 39: 59–66.[CrossRef][Medline]

  38. Barrans, A., B. Jaspard, R. Barbaras, H. Chap, B. Perret, and X. Collet. 1996. Pre-beta HDL: structure and metabolism. Biochim. Biophys. Acta. 1300: 73–85.[Medline]

  39. Oram, J. F., J. J. Albers, M. C. Cheung, and E. L. Bierman. 1981. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J. Biol. Chem. 256: 8348–8356.[Free Full Text]

  40. Sola, R., C. Motta, M. Maille, M. T. Bargallo, C. Boisnier, J. L. Richard, and B. Jacotot. 1993. Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler. Thromb. 13: 958–966.[Abstract]

  41. Wang, N., D. L. Silver, C. Thiele, and A. R. Tall. 2001. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276: 23742–23747.[Abstract/Free Full Text]

  42. Pownall, H. J., and C. Ehnholm. 2005. Enhancing reverse cholesterol transport: the case for phosphatidylcholine therapy. Curr. Opin. Lipidol. 16: 265–268.[Medline]

  43. Girona, F., A. E. LaVille, R. Solà, C. Motta, and L. Masana. 2003. HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages. Biochim. Biophys. Acta. 1633: 143–148.[Medline]

  44. Suc, I., S. Brunet, G. Mitchell, G. E. Rivard, and E. Levy. 2003. Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B. J. Cell Sci. 116: 89–99.[Abstract/Free Full Text]

  45. Fournier, N., V. Atger, A. Cogny, B. Vedie, P. Giral, A. Simon, N. Moatti, and J. L. Paul. 2001. Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis. 157: 315–323.[CrossRef][Medline]

  46. Borggreve, S. E., R. De Vries, and R. P. Dullaart. 2003. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins. Eur. J. Clin. Invest. 33: 1051–1069.[CrossRef][Medline]

  47. Marcil, M., L. Yu, L. Krimbou, J. F. Oram, J. S. Cohn, and J. Genest, Jr. 1999. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler. Thromb. Vasc. Biol. 19: 159–169.[Abstract/Free Full Text]

  48. Francis, G. A., R. H. Knopp, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein AI in Tangier disease. J. Clin. Invest. 96: 78–87.[Medline]

  49. Ueyama, K., M. Yokode, H. Arai, Y. Nagano, Z. X. Li, M. Cho, and T. Kita. 1998. Cholesterol efflux effect of high density lipoprotein is impaired by whole cigarette smoke extracts through lipid peroxidation. Free Radic. Biol. Med. 24: 182–190.[CrossRef][Medline]

  50. Wang, N., D. Lan, W. Chen, F. Matsuura, and A. R. Tall. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA. 101: 9774–9779.[Abstract/Free Full Text]

  51. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982–20985.[Abstract/Free Full Text]

  52. Zhang, W., P. G. Yancey, Y. R. Su, V. R. Babaev, Y. Zhang, S. Fazio, and M. F. Linton. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 108: 2258–2263.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600167-JLR200v1
48/2/328    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berrougui, H.
Right arrow Articles by Khalil, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berrougui, H.
Right arrow Articles by Khalil, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today